Please assess the completion status of the following clinical trial:

Trial Title: Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients (\> 14 years) with suspected severe leptospirosis~* patients who presented with acute fever (oral temperature more than 38.00 C for \<15 days) in the absence of an obvious focus of infection~* In the opinion of the attending physician might have pulmonary hemorrhage (i.e. history of hemoptysis, and/ or bilateral nodular or air space infiltration).~Exclusion Criteria:~* pregnant or breastfeeding~* those with history of bleeding disorder~* those who had underlying diseases such as chronic liver disease, diabetes mellitus~* those who received diuretic or glucocorticoid

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: NO_INTERVENTION): Standard supportive care
- 2 (Type: EXPERIMENTAL): Dexamethasone treatment
- 3 (Type: EXPERIMENTAL): Desmopressin treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).